Key opportunities in the DNA encoded library market include demand for streamlined drug discovery, with a focus on cancer treatments, driven by pharma/biopharma sectors. Growth is expected in ...
HitGen Enters into DNA-Encoded Library Based Drug Discovery Research Collaboration with Galapagos NV
CHENGDU, China--(BUSINESS WIRE)-- HitGen Inc. today announced that it has entered into a drug discovery research collaboration with Galapagos NV to identify potential small molecule leads against ...
In this GEN webinar, our expert speakers will explore cutting-edge drug discovery techniques for target deconvolution and multiplex target discovery.
CHENGDU, China, Nov. 13, 2022 /PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE:688222.SH) today announced that it has entered into a research collaboration agreement ...
CHENGDU, China, July 16, 2024 /PRNewswire/ -- "Evolving DNA-Encoded Library Technology and Its Application for Innovative Drug Discovery" webinar will be jointly hosted by HitGen Inc. and Xtalks on ...
X-Chem, a provider of DNA-encoded libraries for drug discovery, has been bought by the European investment firm GHO Capital Partners for an undisclosed sum from two other investment firms. Based in ...
HitGen Enters into DNA-Encoded Library Based Drug Discovery Research Collaboration with Galapagos NV
CHENGDU, China--(BUSINESS WIRE)--HitGen Inc. today announced that it has entered into a drug discovery research collaboration with Galapagos NV to identify potential small molecule leads against ...
CHENGDU, China--(BUSINESS WIRE)--HitGen Inc. today announced that it has entered into a drug discovery research collaboration with Kymera Therapeutics, Inc., to identify small molecule leads against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback